The reactivity of 95 breast carcinomas with the antibody Ki-67, which recognises a nuclear antigen in proliferating cells, has been assessed and compared to their histological grade and, for 47 tumours, DNA index and S-phase content. This evidence concerns the gene MKI67 and breast carcinoma.